Today: 20 May 2026
Browse Category

LSE:ULVR 1 February 2026 - 30 April 2026

FTSE 100 Today: Why UK Stocks Are Barely Moving as DCC, Unilever and the BoE Dominate London Trading

FTSE 100 Today: Why UK Stocks Are Barely Moving as DCC, Unilever and the BoE Dominate London Trading

The FTSE 100 rose 0.10% to 10,222.85 in early London trading, recovering after a 1.2% drop on Wednesday. DCC shares fell 5% after rejecting a £4.95 billion takeover bid from KKR and Energy Capital Partners. Unilever began a €1.5 billion share buyback and posted 3.8% underlying sales growth. Investors awaited the Bank of England’s rate decision, with no change expected.
30 April 2026
···········
Unilever Stock Price: Why Shares Are Stuck Near 4,840p Despite a €1.5 Billion Buyback

Unilever Stock Price: Why Shares Are Stuck Near 4,840p Despite a €1.5 Billion Buyback

Unilever shares traded near 4,840 pence Thursday, little changed after closing Wednesday at 4,846 pence, down 1.24%. Investors weighed February guidance that 2026 sales growth would hit the low end of its 4%-6% range. The company completed its ice cream demerger in December and plans a €1.5 billion share buyback in the second quarter. The stock remains 12.56% below its December 52-week high.
12 March 2026
··
Unilever PLC Shares Slip as Oil Shock Revives 2026 Growth Doubts After Magnum Spin-Off

Unilever PLC Shares Slip as Oil Shock Revives 2026 Growth Doubts After Magnum Spin-Off

Unilever shares fell 0.64% to 4,903.5 pence in London on Monday amid a Europe-wide selloff triggered by oil prices surging over 25% to nearly $120 a barrel. The company last month warned 2026 sales growth would likely hit the bottom of its 4%-6% target range after weak results in Europe and the U.S. Developed markets make up 41% of turnover; fourth-quarter sales growth slowed to 0.1% in Europe.
9 March 2026
·
Unilever PLC’s India Unit Exits Nutritionalab as Premium Growth Push Gains Pace

Unilever PLC’s India Unit Exits Nutritionalab as Premium Growth Push Gains Pace

Hindustan Unilever has sold its entire 19.8% stake in Nutritionalab for about 3.07 billion rupees, according to a March 4 filing. The sale follows board approval last month to exit Nutritionalab and acquire the remaining 49% of OZiva. HUL’s quarterly profit dropped 15% after price cuts and competition. Parent Unilever expects 2026 sales growth at the lower end of its target range.
6 March 2026
··
FTSE 100 record close meets Iran-oil risk: what could move London stocks this week

FTSE 100 record close meets Iran-oil risk: what could move London stocks this week

The FTSE 100 closed Friday at a record 10,910.55, up 0.6%, marking its third straight all-time high. U.S.-Israeli strikes killed Iran’s Supreme Leader, prompting some oil shipments to pause and Brent crude to hit $73. OPEC+ meets Sunday to discuss a possible April output hike. UK earnings and U.S. payrolls data are expected to influence rate expectations this week.
1 March 2026
········
Unilever share price set for test after €1.5 billion buyback meets cautious 2026 outlook

Unilever share price set for test after €1.5 billion buyback meets cautious 2026 outlook

Unilever expects 2026 growth at the lower end of its 4%-6% target and announced a €1.5 billion share buyback set for the second quarter. Shares fell up to 3.6% after the update, as the company flagged modest margin improvement and plans to sell its 19.9% stake in The Magnum Ice Cream Company. Magnum’s shares dropped over 14% after its first standalone earnings report.
13 February 2026
··
FTSE 100 today: Schroders deal sparks record high, but London shares end lower on weak UK growth

FTSE 100 today: Schroders deal sparks record high, but London shares end lower on weak UK growth

The FTSE 100 closed down 0.67% at 10,402.44 after hitting a record intraday high, as weak GDP and business investment data weighed. Schroders surged on a £9.9 billion takeover offer from Nuveen, the largest-ever for a European fund manager. The FTSE 250 fell 0.48%. Investors expect the Bank of England may cut rates at its March 19 meeting.
12 February 2026
········
Unilever share price flat at Friday close — what could move ULVR ahead of Feb 12 results

Unilever share price flat at Friday close — what could move ULVR ahead of Feb 12 results

Unilever shares closed flat at 5,250 pence Friday, with about 3.2 million shares traded. The company will report full-year results on Feb. 12, its first major update since spinning off its ice cream unit. Investors expect guidance on 2026 sales, margins, and cost savings. Unilever has forecast 2025 underlying sales growth of 3% to 5% and second-half margins of at least 19.5%.
8 February 2026
··
Unilever share price holds at 5,250p as results week looms — what investors watch next

Unilever share price holds at 5,250p as results week looms — what investors watch next

Unilever shares closed flat at 5,250p in London Friday, underperforming the FTSE 100’s 0.6% gain. The company issued 4.2 million new shares for employee plans, bringing total shares to over 2.18 billion. Investors await Q4 and full-year results on Feb. 12, with analyst consensus pointing to 3.9% Q4 sales growth. Unilever’s U.S. ADR rose 0.8% to $72.12.
7 February 2026
··
UK stock market today: FTSE 100 steadies as miners tumble in metals rout, BoE looms

UK stock market today: FTSE 100 steadies as miners tumble in metals rout, BoE looms

FTSE 100 edged up 0.1% by late morning as defensive shares offset sharp losses in mining stocks. Commodity prices tumbled after President Trump nominated Kevin Warsh as Fed chair, with gold down 5% and silver over 7%. FTSE 250 fell 0.4%, led by declines in Auction Technology Group and Ocado. UK manufacturing PMI rose to 51.8 in January, signaling growth.
2 February 2026
·············
1 2 3 4

Stock Market Today

  • Tesla Q1 2026 Earnings Beat; Stock Faces Mixed Outlook for 2030
    May 20, 2026, 10:24 AM EDT. Tesla (TSLA) reported Q1 2026 earnings per share (EPS) of $0.41, exceeding the $0.36 consensus, with automotive gross margin rising to 21.1% from 16.2%. Operating income increased 135.8% year-on-year (YoY), and services plus Full Self-Driving (FSD) revenue jumped 42% to $3.75 billion, with 1.28 million active FSD subscriptions up 51%. Despite strong fundamentals, Tesla shares fell 8.83% year-to-date to $409.99 amid skepticism about AI monetization and scaling autonomy. Wall Street's average target is about $412, while a proprietary model estimates a base case price of $510 by 2030, with a bull case of $645. Achieving $650 requires significant price-to-earnings multiple expansion or sharp EPS growth from AI ventures, amid challenges like increased operating expenses and production constraints.

Latest articles

POET Technologies Jumps After $400M AI Photonics Raise, Dilution Questions Linger

POET Technologies Jumps After $400M AI Photonics Raise, Dilution Questions Linger

20 May 2026
POET Technologies shares rose 11% to $14.55 in early Nasdaq trading Wednesday after closing a US$400 million direct offering of 19 million shares and warrants. The rebound followed an 8% drop Tuesday on dilution concerns. The company reported Q1 revenue of $503,389 and a net loss of $12.3 million. A recent $50 million order from Lumilens could scale to $500 million over five years if production ramps up.
Nokia’s U.S. Broadband Order Arrives While AI-Driven Gains Test Supply Chain

Nokia’s U.S. Broadband Order Arrives While AI-Driven Gains Test Supply Chain

20 May 2026
Nokia shares rose 3.37% in Helsinki trading Wednesday after the FCC conditionally approved its Beacons and ONT devices, exempting them from U.S. Covered List restrictions. Nokia also transferred 975,289 treasury shares to equity plan participants. Dell’Oro Group forecasts the optical transport equipment market will grow 16% in 2026, driven by AI data centers.
Apellis Shares Disappear After Biogen’s $5.6 Billion Buy—One Play Left

Apellis Shares Disappear After Biogen’s $5.6 Billion Buy—One Play Left

20 May 2026
Biogen completed its acquisition of Apellis Pharmaceuticals, removing APLS shares from Nasdaq and paying investors $41 per share plus a contingent value right tied to Syfovre sales. Apellis shareholders tendered 82.4% of outstanding stock before the offer expired May 13. Biogen shares rose 0.9% to $192.34 Wednesday. The CVR could pay up to $4 if Syfovre meets future sales targets.
Go toTop